<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="letter" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Our Dermatol Online</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-10-306</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20193.25</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letter to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Idiopathic pyoderma gangrenosum</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lamouaffaq</surname>
<given-names>Amina</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gallouj</surname>
<given-names>Salim</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baybay</surname>
<given-names>Hanane</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mernissi</surname>
<given-names>Fatima Zahra</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
</contrib-group>
<aff id="aff1"><italic>Department of Dermatology, University Hospital Hassan II Fez, Morocco</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Amina Lamouaffaq, E-mail: <email xlink:href="a.lamouaffaq@gmail.com">a.lamouaffaq@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<volume>10</volume>
<issue>3</issue>
<fpage>307</fpage>
<lpage>306</lpage>
<history>
<date date-type="received"><day>25</day><month>09</month><year>2018</year></date>
<date date-type="accepted"><day>04</day><month>12</month><year>2018</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 3</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
</article-meta>
</front>
<body>
<sec id="sec1-1">
<title/>
<p>Sir,</p>
<p>A 36-year-old patient with no pathological pathology who presented 6 months before admission pustular lesions increasing in size and number and becoming ulcerated in the legs of centrifugal evolution, painful, without other associated signs including rheumatological digestive or other (Figs. <xref ref-type="fig" rid="F1">1a</xref> &#x2013; <xref ref-type="fig" rid="F1">1d</xref>).</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>(a-d) Ulcerations well limited, with raised, erythematous - purplish and inflammatory margins.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-10-306-g001.tif"/>
</fig>
<p>Clinical examination revealed multiple ulcers, well limited, purplish, necrotic in center, of varying sizes, the edges was raised with pus. The lesions were in the legs and there were no extra cutaneous manifestations. Biological tests were normal and the histology was in favor of pyoderma gangrenosum. The Idiopathic one was suggested due to exclusion of other usual associations.</p>
<p>The patient was treated by oral corticotherapy with good evolution.</p>
<p>Pyoderma gangrenosum (PG) is a neutrophilic dermatosis with unclear etiology [<xref ref-type="bibr" rid="ref1">1</xref>]. Described in 1930 by Brunstig et al [<xref ref-type="bibr" rid="ref2">2</xref>]. It is a noninfectious disease characterized by necrotizing, ulcerative and painful skin, whose incidence is approximately 3-10 cases per million people per year and it is rarely observed in children, accounting for less than 4&#x0025; of cases, but primarily affects adults between the ages of 25 and 54 years old without gender preference [<xref ref-type="bibr" rid="ref3">3</xref>]. PG can associate with inflammatory, infectious or malignant pathologies or be idiopathic [<xref ref-type="bibr" rid="ref4">4</xref>]. It presents initially with coalescent inflammatory pustules, which fuse progressively leaving reveal a necrotic ulcer, with hypertrophic edges well defined, of purplish color. The base of the ulcer is often under-mined, indicating early subcutaneous inflammatory extension, with secondary ulceration of the epidermis, the lesions predominate classically in the lower limbs or the trunk, but can be observed on the whole of the cutaneous surface. Exceptionally, il may spread to extracutaneous tissues, with pulmonary infiltrates or joint involvement simulating true septic arthritis.</p>
<p>PG remains at present a clinical diagnosis of exclusion. The histological aspect reveals most often nonspecific, but helps to exclude other potential causes [<xref ref-type="bibr" rid="ref5">5</xref>].</p>
<p>The evocative histology includes a dense and deep dermal infiltrate consisting of neutrophils without vasculitis, associated with a necrotic ulceration appearance, and the treatment remains poorly codified to date. It is mainly based on general or local corticosteroids, immunosuppressors and certain anti-inflammatory antibiotics [<xref ref-type="bibr" rid="ref2">2</xref>].</p>
<sec id="sec2-1">
<title>Consent</title>
<p>The examination of the patient was conducted according to the Declaration of Helsinki principles.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Afifi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Braswell</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Ortega-Loayza</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Shinkai</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review</article-title>
<source>J Am Acad Dermatol</source>
<year>2018</year>
<volume>78</volume>
<fpage>1195</fpage>
<lpage>204</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anuset</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Reguiai</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Perceau</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Colomb</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Durlach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>[Clinical patterns and treatment of pyoderma gangrenosum in a French department]</article-title>
<source>Ann Dermatol Venereol</source>
<year>2016</year>
<volume>143</volume>
<fpage>108</fpage>
<lpage>17</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Dossary</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Tariq</surname>
<given-names>S</given-names>
</name>
<name>
<surname>AlFawaz</surname>
</name>
<name>
<surname>Awatif</surname>
<given-names>K. AlMutairi</given-names>
</name>
</person-group>
<article-title>Pyoderma gangrenosum with splenic involvement</article-title>
<source>Int J Ped Adoles Med</source>
<year>2016</year>
<volume>3</volume>
<fpage>78</fpage>
<lpage>80</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabhi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zaouak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koubaa</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hammami</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fenniche</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Pyoderma Gangr&#233;nosum: &#224;propos de 14 cas</article-title>
<source>Rev M&#233;d Intern</source>
<year>2017</year>
<volume>38S</volume>
<fpage>A109</fpage>
<lpage>A248</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carron</surname>
<given-names>P.-N</given-names>
</name>
<name>
<surname>Yerly</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ksontini</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Meylan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Calandra</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Pyoderma gangrenosum: diagnostic and therapeutic challenge</article-title>
<source>Rev Med Suisse</source>
<year>2008</year>
<volume>4</volume>
<fpage>1938</fpage>
<lpage>43</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>
